Clinical Trials
10
Active:8
Completed:0
Trial Phases
2 Phases
Phase 1:8
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 1
8 (80.0%)Phase 3
2 (20.0%)HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase 3
Terminated
- Conditions
- Prostate Cancer MetastaticCastration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2019-02-22
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Hinova Pharmaceuticals USA, Inc.
- Target Recruit Count
- 104
- Registration Number
- NCT03850795
- Locations
- 🇺🇸
Urology Center of Colorado, 2777 Mile High Stadium Circle, Denver, Colorado, United States
🇺🇸Urologic Surgeons of Washington, Washington, District of Columbia, United States
🇺🇸First Urology PSC, 101 Hospital Boulevard, Jeffersonville, Indiana, United States
News
No news found